PT UBC Medical Indonesia Tbk
PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. It operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. The company offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products. PT UBC Medical Indonesia Tbk was founded in 2014 and is based in Jakarta Timur… Read more
PT UBC Medical Indonesia Tbk (LABS) - Total Assets
Latest total assets as of September 2025: Rp217.49 Billion IDR
Based on the latest financial reports, PT UBC Medical Indonesia Tbk (LABS) holds total assets worth Rp217.49 Billion IDR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
PT UBC Medical Indonesia Tbk - Total Assets Trend (2021–2024)
This chart illustrates how PT UBC Medical Indonesia Tbk’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
PT UBC Medical Indonesia Tbk - Asset Composition Analysis
Current Asset Composition (December 2024)
PT UBC Medical Indonesia Tbk's total assets of Rp217.49 Billion consist of 78.1% current assets and 21.9% non-current assets.
| Asset Category | Amount (IDR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 20.9% |
| Accounts Receivable | Rp26.24 Billion | 12.9% |
| Inventory | Rp71.85 Billion | 35.3% |
| Property, Plant & Equipment | Rp33.45 Billion | 16.4% |
| Intangible Assets | Rp5.34 Billion | 2.6% |
| Goodwill | Rp0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how PT UBC Medical Indonesia Tbk's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PT UBC Medical Indonesia Tbk's current assets represent 78.1% of total assets in 2024, an increase from 62.0% in 2021.
- Cash Position: Cash and equivalents constituted 20.9% of total assets in 2024, up from 12.2% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 35.3% of total assets.
PT UBC Medical Indonesia Tbk Competitors by Total Assets
Key competitors of PT UBC Medical Indonesia Tbk based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
PT UBC Medical Indonesia Tbk - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - PT UBC Medical Indonesia Tbk generates 0.73x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, PT UBC Medical Indonesia Tbk generates $ 1.45 in net profit.
PT UBC Medical Indonesia Tbk - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.85 | 3.19 | 1.94 |
| Quick Ratio | 1.55 | 1.73 | 0.97 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rp118.33 Billion | Rp 132.72 Billion | Rp 56.90 Billion |
PT UBC Medical Indonesia Tbk - Advanced Valuation Insights
This section examines the relationship between PT UBC Medical Indonesia Tbk's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 27.0% |
| Total Assets | Rp203.60 Billion |
| Market Capitalization | $6.71 Million USD |
Valuation Analysis
Below Book Valuation: The market values PT UBC Medical Indonesia Tbk's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: PT UBC Medical Indonesia Tbk's assets grew by 27.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for PT UBC Medical Indonesia Tbk (2021–2024)
The table below shows the annual total assets of PT UBC Medical Indonesia Tbk from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Rp203.60 Billion | +27.02% |
| 2023-12-31 | Rp160.29 Billion | +47.42% |
| 2022-12-31 | Rp108.73 Billion | +14.46% |
| 2021-12-31 | Rp94.99 Billion | -- |